| Literature DB >> 34070327 |
Federica Fati1, Rebecca Pulvirenti1, Irene Paraboschi2,3, Giuseppe Martucciello2,3.
Abstract
Neuroblastoma (NB) is the most commonly occurring soft-tissue malignancy of childhood. Surgery plays an important role in multidisciplinary treatment and its principal aim is a local control of the disease, respecting the integrity of the surrounding structures. There is no unanimous consensus on the best surgical technique, and the operative approach largely depends on the anatomical location and the extension of the mass. To have a complete overview of the different type of treatment, we made a review of the literature from the last twenty years of all the surgical approaches applied for NBs resection, accordingly to the anatomical site.Entities:
Keywords: innovative techniques; laparoscopy; laparotomy; neuroblastoma; surgery; thoracoscopy; thoracotomy
Year: 2021 PMID: 34070327 PMCID: PMC8227756 DOI: 10.3390/children8060446
Source DB: PubMed Journal: Children (Basel) ISSN: 2227-9067
Figure 1Patient’s position and site of incision in thoracotomy (A) and thoracoscopy (B), respectively.
Comparation of surgical technique for thoracic NBs. (TS = Thoracoscopic; TT = Thoracotomy; NB = neuroblastoma; GNB = ganglio neuroblastoma; GN = ganglioneuroma; MPST = Malignant peripheral nerve sheath tumor ND = not defined).
| Author/Year | Age (Months) | Surgical Approach | Operative Time (Minutes) | Conversion | Stage | Type | N-Myc ampL | Hospital Stay (Days) | Post-Operative Complication | Outcome | Follow Up Months | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Decou, J. | 5 | 27.2 | TS | 108.6 | none | 1 | NB | no | 2.6 | 2 spillage | alive, complete remission | 29.2 |
| Fraga, J.C. | 43 | 36 | TT ( | TT 132; TS 180 | none | 8 stage I, 11 stage II, 8 stage III, 6 stage IV, 3 stage IVS | 10 NB, | ND | TT 6; TS 4 | 5 Horner syndr 2 chylothorax; 2 pnuemothorax, 1 empiema, 1 tracheomalacia and paralysis of diaphragm | 4 recurrences, | 41.5 |
| Fraga, J.C. | 17 | 16 | TS | 90 | none | 4 stage I, 5 stage II, 3 stage III, 1 stage IV-S | 10 NB, | 3 | 2 Horner syndrome | alive, complete remission | 16 | |
| Irtan, S. | 20 | 39 | TS | ND | 2 | 5 L1, 5 L2, 7 M, 3 MS | 3 GN, | ND | ND | 1 Horner syndr, 3 chylothorax | alive, complete remission | 33 |
| Lacreuse, I. | 21 | 72 | TS | 100 | none | ND | 9 NB, | no | 4.5 | 2 chylothorax | alive, complete remission | 48 |
| Malek, M.M. | 37 | 13 (TS), | TS ( | TS 150, TT 180 | none | 10 stage I, 18 stage II 18, 3 stage III, 4 stage IV | NB | 2 | TS 2, TT 3.5 | 2 Horner’s syndrome, 1 chylothorax, 1 postoperative scoliosis, and 1 severe atelectasis | 5 recurrence, 23 free survival | ND |
| Nio, M. | 6 | 42 | TS | 230 | none | ND | 1 NB, | ND | 7.6 | none | ND | 49 |
| Petty, J.K. | 17 | 10 (TS), | TS ( | TS 54, TT 138 | 1 | 5 stage I, 3 stage II, 2 stage IV | 10 NB, | ND | TS 2, TT 4 | 5 Horner syndr, 1 pleural effusion | 1 tumour progression | 19 |
Figure 2Patient’s position and site of incision/trocars in laparotomy (A) and laparoscopy (B), respectively, for left adrenal NBs.
Figure 3Trocars site for right (A) and left (B) lateral laparoscopic adrenalectomy.
Figure 4Trocars site for retroperitoneal laparoscopic adrenalectomy.
Comparison of surgical techniques for adrenalectomy. (TLLA = Transperitoneal Lateral Laparoscopic Adrenalectomy; LA = Laparoscopic Adrenalectomy; TLA = Transperitoneal Laparoscopic Adrenalectomy; RPSA = Retroperineoscopic Adrenalectomy; OA = Open Adrenalectomy; * = Open Adrenalectomy group).
| Author/Year | Age (Months) | Surgical Approach | Operative Time (Minutes) | Conversion | Hospital Stay (Days) | Post-Operative Complication | Outcome | Follow Up Months | |
|---|---|---|---|---|---|---|---|---|---|
| Catellani et al., 2014 [ | 4 | 87 | TLLA | 85–125 | 0 | 3.75 | 0 | Alive, no disease recurrence | 35.25 |
| Mirallié et al., 2001 [ | 6 | 97.34 | LA | 191.25 | 2 | / | 0 | 1 patient remained hypertensive | 1 |
| Mitra et al., 2020 [ | 3 | 76 | Robotic-assisted LA | 244 | 0 | 2 | 1 morbilliform eruption | Alive, no disease recurrence | 19 |
| Al-Shanafey 2008 [ | 29 | 36 | TLA | 144 | 3 | 2 | 0 | Alive, no disease recurrence | 36 |
| De Barros et al., 2012 [ | 7 | 27 | TLA | 138.6 | 1 | 2.9 | 0 | Alive, no disease recurrence | 18.8 |
| De Lagausie et al., 2003 [ | 9 | 38 | LA | / | 1 | 4.5 | 1 | 1 disease recurrence | / |
| Fascetti Leon et al., 2016 [ | 68 | 62 | 63 TLA | 227.5 | / | 4.5 | / | 2 disease recurrence | 52 |
| Kadamba et al., 2004 [ | 10 | 48 | TLA | 235.5 | 2 | 3 | 0 | 1 death for tumor dissemination, | 24 |
| Kelleher et al., 2013 [ | 79 | 32.3 | 61 OA | OA 292 | 2 | OA 10.4 | 1 sepsis (LPT group) | 23 deaths | OA 56.5 |
| Kouch et al., 2003 [ | 6 | 8.5 | RPSA | 195 | 0 | / | / | Alive, no disease recurrence | 15-29 |
| Lopes et al., 2012 [ | 19 | 46.8 | LA | 138.5 | 0 | 3.5 | 0 | 4 disease recurrence | 81 |
| Mattioli et al., 2014 [ | 55 | 14 | LA | 90 | 0 | 4 | 0 | Alive, no disease recurrence | 27 |
| Nerli et al., 2011 [ | 18 | 69.6 | LA | 95 | 0 | 2 | 0 | Alive, no disease recurrence | 39 |
| Peter et al., 2011 [ | 140 | 105.6 | LA | 140.7 | 13 | / | 1 renal infarction | 1 local recurrence | 18 |
| Saad et al., 2005 [ | 6 | 26.2 | LA | 149.2 | 0 | 1 | 0 | / | 21 |
| Yao et al., 2018 [ | 37 | 37.24 | 24 OA | OA 143.13 | 2 | 2 | / | 2 disease recurrence * | 86.78 |
| Meignan et al., 2017 [ | 3 | 11.7 | Robot-assisted LA | 104.3 | 0 | 2.3 | 0 | Alive, no disease recurrence | 41.6 |
| Stanford et al., 2002 [ | 64 | OA 106.8 | 60 OA | OA 236 | / | OA 5.4 | 0 | 2 local recurrence | / |
| Romano et al., 2007 [ | 26 | OA 41.7 | 19 OA | OA 203.7 | 0 | / | 0 | 3 deaths * | / |
Figure 5Thoracophrenolaparotomic incision for thoraco-abdominal NBs.
Figure 6Posterior sagittal incision for pelvic NBs.